SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
----------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) JUNE 29, 2004
---------------
INTERPHARM HOLDINGS, INC.
--------------------------------------------------
(Exact name of Registrant as specified in charter)
Delaware 0-22710 13-3673965
------------------------- ------------- -------------------
(State or other jurisdic- (Commission (IRS Employer
tion of incorporation) File Number) Identification No.)
69 Mall Drive, Commack, New York 11725
---------------------------------------- ----------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (631) 543-2800
--------------
ITEM 5. OTHER EVENTS AND REGULATION FD DISCLOSURE.
On June 30, 2004, Interpharm Holdings, Inc. issued a press release
announcing the June 29, 2004 closing of the acquisition of a 92,000 square foot
facility on thirty seven acres of land, located in Yaphank, New York. A copy of
the press release is furnished as an Exhibit to this Current Report on Form 8-K
(Exhibit 99.1).
EXHIBIT NO. DESCRIPTION.
----------- ---------------------------------------------------------------
99.1 Press release of Interpharm Holdings, Inc. dated June 30, 2004.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
INTERPHARM HOLDINGS, INC.
June 30, 2004
By: /S/ GEORGE ARONSON
-------------------------
George Aronson
Chief Financial Officer